Loading…
Incyte Corporation is projected to rise to $166.93 by 2027, a +28% move from its current price of $129.93. INCY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $127.38 | $129.95 | $132.58 | +0.02% |
| Aug 1 | $126.35 | $129.98 | $133.71 | +0.04% |
| Aug 2 | $125.58 | $130.00 | $134.59 | +0.06% |
| Aug 3 | $124.93 | $130.03 | $135.33 | +0.07% |
| Aug 4 | $124.36 | $130.05 | $136.00 | +0.09% |
| Aug 5 | $123.86 | $130.08 | $136.61 | +0.11% |
| Aug 6 | $123.39 | $130.10 | $137.17 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $123.39 | $130.10 | $137.17 | +0.13% |
| Week 2 | $120.88 | $130.27 | $140.39 | +0.26% |
| Week 3 | $119.02 | $130.44 | $142.96 | +0.39% |
| Week 4 | $117.50 | $130.61 | $145.20 | +0.53% |
| Week 5 | $116.19 | $130.78 | $147.21 | +0.66% |
| Week 6 | $115.03 | $130.96 | $149.08 | +0.79% |
| Week 7 | $114.00 | $131.13 | $150.84 | +0.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Incyte Corporation (INCY) is a healthcare sector biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. It maintains a diverse portfolio of therapeutics across oncology, hematology and dermatology, including JAKAFI, ICLUSIG, MONJUVI/ MINJUVI, NIKTIMVO, INCA033989, INCA035784, INCB160058, PEMAZYRE, and ZYNYZ, among others. The company was incorporated in 1991 and was formerly known as Incyte Genomics Inc; it is headquartered in Wilmington, Delaware.
INCY trades with a current price of $129.93 per share and a market capitalization of $25.96B, ranking 488 in market size.
The price outlook shown in the forecast highlights upside potential, with the 2026 average price listed as $129.93 and substantial gains projected in later years (2030 average $259.94, 2040 average $1,009.86, and 2050 average $2,084.15).
Forecast sentiment shifts from Neutral in 2026 to Bullish from 2027 onward, aligning with a rising path in the annual avg prices and growing ROI over the long horizon.
A major floor 32.5% below — a decisive break under it would weaken the trend.
The nearest floor, 24.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 16.3% above — clearing it would confirm fresh momentum.
Key INCY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INCY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $119.79 | Buy | $121.65 | Buy |
| MA 10 | $118.10 | Buy | $119.18 | Buy |
| MA 20 | $117.01 | Buy | $116.29 | Buy |
| MA 50 | $107.46 | Buy | $110.04 | Buy |
| MA 100 | $101.45 | Buy | $105.03 | Buy |
| MA 200 | $100.68 | Buy | $98.95 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 76.76 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 457.33 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.40 | Buy |
| ROC (12) | 11.33 | Buy |
| Bollinger %B (20,2) | 1.47 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.46 | Buy |
| Awesome (5,34) | 7.54 | Buy |
| Ultimate (7,14,28) | 79.33 | Sell |
| Momentum (10) | 15.05 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 121.94 | Buy |
| ADX (14) | 26.37 | Buy |
| ATR (14) | 2.22 | Info |
The 30-day technical picture is bullish, with RSI14 at 80 indicating strong momentum.
The price is trading above both the SMA50 and SMA200, which stand at $107.46 and $100.68 respectively, suggesting an overall bullish trend.
Over the last 30 days, the price range has been between $113.88 and $148.24, with a near-term resistance at $129.93 and a support level at $98.22.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $90.30 | $129.93 | $170.45 | 0% | Neutral | |
| $136.34 | $166.93 | $213.95 | +28% | Bullish | |
| $159.73 | $199.54 | $263.15 | +54% | Bullish | |
| $176.83 | $224.56 | $302.86 | +73% | Bullish | |
| $201.76 | $259.94 | $357.28 | +100% | Bullish | |
| $263.36 | $343.76 | $480.38 | +165% | Bullish | |
| $307.65 | $406.44 | $576.52 | +213% | Bullish | |
| $340.68 | $455.18 | $654.46 | +250% | Bullish | |
| $381.54 | $515.21 | $750.10 | +297% | Bullish | |
| $395.83 | $539.95 | $795.32 | +316% | Bullish | |
| $707.51 | $1,009.86 | $1,562.45 | +677% | Bullish | |
| $1,353.83 | $2,084.15 | $3,467.62 | +15.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $90.30 | $129.93 | $152.07 | +0.00% |
| August 2026 | $111.57 | $130.27 | $155.14 | +0.26% |
| September 2026 | $112.52 | $132.17 | $158.94 | +1.46% |
| October 2026 | $116.03 | $136.94 | $165.96 | +3.61% |
| November 2026 | $116.97 | $138.60 | $169.03 | +1.21% |
| December 2026 | $116.85 | $138.96 | $170.45 | +0.26% |
Click any year to see its month-by-month INCY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The INCY price prediction for 2026 points to an average of $129.93 (low $90.30, high $170.45) — a potential gain of 0% on today's $129.93. Price action looks broadly range-bound.
In 2027, INCY is projected to trade between $136.34 and $213.95, averaging $166.93 — a potential gain of +28% from today's $129.93. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Incyte Corporation's 2028 outlook centres on $199.54, within a $159.73 to $263.15 range. That is up +20% on the projected 2027 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2029, INCY could reach as high as $302.86, with a base case around $224.56 and support toward $176.83 — roughly +73% from $129.93. Buyers look set to stay in control over this stretch.
Expect INCY to range from $201.76 to $357.28 through 2030. The $259.94 average target implies a +100% move from current prices. That is up +16% on the projected 2029 average. Momentum favours further upside here.
The INCY price prediction for 2031 points to an average of $343.76 (low $263.36, high $480.38) — a potential gain of +165% on today's $129.93. Buyers look set to stay in control over this stretch.
In 2032, INCY is projected to trade between $307.65 and $576.52, averaging $406.44 — a potential gain of +213% from today's $129.93. That is up +18% on the projected 2031 average. Momentum favours further upside here.
Incyte Corporation's 2033 outlook centres on $455.18, within a $340.68 to $654.46 range. That is up +12% on the projected 2032 average. That marks a +250% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, INCY could reach as high as $750.10, with a base case around $515.21 and support toward $381.54 — roughly +297% from $129.93. Momentum favours further upside here.
Expect INCY to range from $395.83 to $795.32 through 2035. The $539.95 average target implies a +316% move from current prices. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The INCY price prediction for 2040 points to an average of $1,009.86 (low $707.51, high $1,562.45) — a potential gain of +677% on today's $129.93. Momentum favours further upside here.
In 2050, INCY is projected to trade between $1,353.83 and $3,467.62, averaging $2,084.15 — a potential gain of +15.0x from today's $129.93. That is up +106% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in INCY today (≈ 7.696452 INCY) could be worth
$16,040.56
+$15,040.56 (+1504%) by 2050 · US Dollar
Based on the average projected INCY price of $2,084.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INCYwould be worth at today's price.
$1,000 invested in INCY on Jul 28, 2025 (≈ 14.253135 INCY) would be worth
$1,851.91
+$851.91 (+85.2%) today · 1.85× · US Dollar
Based on a INCY entry price of $70.16 vs. today's $129.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $117.39 | $1,106.82 | +10.7% |
| 1 month ago | $114.66 | $1,133.18 | +13.3% |
| 3 months ago | $99.1 | $1,311.1 | +31.1% |
| 6 months ago | $101.08 | $1,285.42 | +28.5% |
| 1 year ago | $70.16 | $1,851.91 | +85.2% |
| All time (5.0y) ago | $78.47 | $1,655.79 | +65.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INCY forecast.
Our base-case forecast reaches $260.00 around 2031.
Implied market cap at $260.00: $51.94B
The multi-year forecast shows a steady, extended uptrend, with the 2027 average price at $166.93 and a 28.5% ROI, followed by 2028 at $199.54 (53.6% ROI) and 2029 at $224.56 (72.8% ROI). By 2030, the average price is projected to $259.94 with a 100.1% ROI, and the path continues higher through 2031–2035 (e.g., 2031 average $343.76, 2032 $406.44, 2033 $455.18, 2034 $515.21, 2035 $539.95).
Longer-horizon forecasts extend to 2040 with an average of $1,009.86 and a 677.2% ROI, and to 2050 with an average of $2,084.15 and a 1504.1% ROI. The accompanying sentiment remains BULLISH across 2027–2050. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $259.94, Min $201.76, Max $357.28, ROI 100.1%, sentiment BULLISH.
The forecast shows upside across years, with 2027 avg $166.93 and ROI 28.5; 2028 avg $199.54 and ROI 53.6; 2029 avg $224.56 and ROI 72.8; 2030 avg $259.94 and ROI 100.1; 2040 avg $1,009.86 and ROI 677.2; 2050 avg $2,084.15 and ROI 1504.1.
Yes, the forecasted average price for 2040 is $1,009.86.
Avg $2,084.15, Min $1,353.83, Max $3,467.62, ROI 1504.1%, sentiment BULLISH.
Incyte Corporation Community Discussion
0Share your Incyte Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.